VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 144 filers reported holding VENTYX BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,082,105 | +11.6% | 1,096,519 | +5.4% | 0.00% | 0.0% |
| Q2 2023 | $34,115,214 | +69.8% | 1,040,098 | +73.4% | 0.00% | +100.0% |
| Q1 2023 | $20,094,205 | -44.5% | 599,827 | -45.7% | 0.00% | 0.0% |
| Q4 2022 | $36,200,554 | +135.2% | 1,104,012 | +150.4% | 0.00% | 0.0% |
| Q3 2022 | $15,393,000 | +286.9% | 440,943 | +35.5% | 0.00% | – |
| Q2 2022 | $3,979,000 | +71.3% | 325,336 | +90.0% | 0.00% | – |
| Q1 2022 | $2,323,000 | +12.9% | 171,195 | +65.2% | 0.00% | – |
| Q4 2021 | $2,058,000 | – | 103,605 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |